Search Results - "ALANEN, Kalle"
-
1
High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer
Published in PloS one (28-06-2012)“…Prostate cancer is a heterogeneous group of diseases and there is a need for more efficient and targeted methods of treatment. In this study, the potential of…”
Get full text
Journal Article -
2
FZD4 as a Mediator of ERG Oncogene―Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
Published in Cancer research (Chicago, Ill.) (01-09-2010)“…TMPRSS2-ERG and other gene fusions involving ETS factors and genes with strong promoter elements are common in prostate cancer. Although ERG activation has…”
Get full text
Journal Article -
3
Arachidonic Acid Pathway Members PLA2G7 , HPGD , EPHX2 , and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer
Published in The American journal of pathology (01-02-2011)“…The arachidonic acid and prostaglandin pathway has been implicated in prostate carcinogenesis, but comprehensive studies of the individual members in this key…”
Get full text
Journal Article -
4
A Prospective Diagnostic Accuracy Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Multidetector Row Computed Tomography, and Magnetic Resonance Imaging in Primary Diagnosis and Staging of Pancreatic Cancer
Published in Annals of surgery (01-12-2009)“…To prospectively compare the accuracy of combined positron emission tomography/computed tomography using F-fluorodeoxyglucose (FDG-PET/CT), multidetector row…”
Get full text
Journal Article -
5
Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma
Published in Oral oncology (01-06-2011)“…Summary In several recent studies, CD44 expression has been associated with aggressive behavior in cancers of different types. CD44 expression is also linked…”
Get full text
Journal Article -
6
Stat3 Promotes Metastatic Progression of Prostate Cancer
Published in The American journal of pathology (01-06-2008)“…There are currently no effective therapies for metastatic prostate cancer because the molecular mechanisms that underlie the metastatic spread of primary…”
Get full text
Journal Article -
7
Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study
Published in The Journal of nuclear medicine (1978) (01-08-2015)“…Accurate diagnosis of the nature of pancreatic cysts is challenging but more important than ever, in part because of the increasing number of incidental cystic…”
Get full text
Journal Article -
8
Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo
Published in Endocrine-related cancer (01-06-2010)“…There are no effective therapies for disseminated prostate cancer. Constitutive activation of Stat5 in prostate cancer is associated with cancer lesions of…”
Get full text
Journal Article -
9
Nuclear Stat5a/b predicts early recurrence and prostate cancer–specific death in patients treated by radical prostatectomy
Published in Human pathology (01-03-2013)“…Summary There is an urgent need for reliable markers to identify patients whose prostate cancer (PCa) will recur after initial therapy and progress to lethal…”
Get full text
Journal Article -
10
Inhibition of Transcription Factor Stat5 Induces Cell Death of Human Prostate Cancer Cells
Published in The Journal of biological chemistry (18-07-2003)“…Identifying regulators of prostate cancer cell survival may lead to new therapeutic strategies for prostate cancer. We now report prevalent activation of…”
Get full text
Journal Article -
11
Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium
Published in The Journal of experimental medicine (15-10-2001)“…Continuous lymphocyte recirculation between blood and lymphoid tissues forms a basis for the function of the immune system. Lymphocyte entrance from the blood…”
Get full text
Journal Article -
12
Group IIA phospholipase A₂ as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality
Published in APMIS : acta pathologica, microbiologica et immunologica Scandinavica (01-03-2009)“…Group IIA Phospholipase A₂ (PLA2-IIA), a key enzyme in arachidonic acid and eicosanoid metabolism, participates in a variety of inflammatory processes but…”
Get full text
Journal Article -
13
Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT
Published in European journal of radiology (01-11-2012)“…We aimed to study the ability of contrast enhanced MRI at 1.5T and 11C-acetate PET/CT, both individually and using fused data, to detect localized prostate…”
Get full text
Journal Article -
14
Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy
Published in The Journal of nuclear medicine (1978) (01-11-2010)“…We assessed the ability of (11)C-acetate PET/CT, MRI, and proton MR spectroscopy ((1)H-MRS) to image localized prostate cancer and detect its aggressiveness,…”
Get full text
Journal Article -
15
Vascular Adhesion Protein 1 Mediates Binding of Immunotherapeutic Effector Cells to Tumor Endothelium
Published in The Journal of immunology (1950) (01-06-2001)“…Tumor-infiltrating lymphocytes (TIL) can be used as an immunotherapeutic tool to treat cancer. Success of this therapy depends on the homing and killing…”
Get full text
Journal Article -
16
Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer
Published in Analytical cellular pathology (Amsterdam) (01-01-2010)“…BACKGROUNDTranscription factor Stat5a/b is highly critical for the viability of human prostate cancer cells in vitro and for prostate tumor growth in vivo…”
Get full text
Journal Article -
17
Altered expression of syndecan-1 in prostate cancer
Published in APMIS : acta pathologica, microbiologica et immunologica Scandinavica (01-02-2004)“…Syndecan‐1 is a cell surface heparan sulfate proteoglycan expressed by epithelial cells. It interacts with growth factors, matrix components, and other…”
Get full text
Journal Article -
18
In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548
Published in Clinical cancer research (01-10-2013)“…A novel [(68)Ga]-labeled DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 peptide (BAY86-7548) having high affinity to…”
Get full text
Journal Article -
19
Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy
Published in Journal of magnetic resonance imaging (01-05-2015)“…Purpose To find the diagnostic accuracy of 3T multiparametric magnetic resonance imaging (mpMRI) and mpMRI targeted transrectal ultrasound (TRUS)‐guided biopsy…”
Get full text
Journal Article -
20
Immunohistochemical labelling for prostate-specific antigen in breast carcinomas
Published in Breast cancer research and treatment (01-07-1999)“…Immunohistochemical detection of prostate-specific antigen (PSA) is an aid in determining the prostatic origin of metastatic cells. However, small amounts of…”
Get full text
Journal Article